{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:00:57Z","timestamp":1778914857267,"version":"3.51.4"},"reference-count":55,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,15]]},"DOI":"10.18632\/oncotarget.12579","type":"journal-article","created":{"date-parts":[[2016,10,12]],"date-time":"2016-10-12T04:56:23Z","timestamp":1476248183000},"page":"76006-76020","source":"Crossref","is-referenced-by-count":20,"title":["Autocrine interleukin-23 promotes self-renewal of CD133+ ovarian cancer stem-like cells"],"prefix":"10.18632","volume":"7","author":[{"given":"Dan","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Xiang","sequence":"additional","affiliation":[{"name":"Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China"},{"name":"Department of Oncology, No. 421 Hospital of PLA, Guangzhou 510318, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongquan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, Fuzhou General Hospital, Fuzhou, Fujian 350025, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailong","family":"Lin","sequence":"additional","affiliation":[{"name":"Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pin","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lupin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiqing","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Southwest Hospital, Third Military Medical University, Chongqing 400038, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2016,10,12]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3322\/ca.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Thun","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"2","doi-asserted-by":"publisher","first-page":"4311","DOI":"10.1158\/0008-5472.can-08-0364","article-title":"Identification and characterization of ovarian cancer-initiating cells from primary human tumors","volume":"68","author":"Nephew","year":"2008","journal-title":"Cancer Res"},{"key":"3","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1038\/sj.bjc.6605626","article-title":"Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant","volume":"102","author":"Jaffe","year":"2010","journal-title":"Br J Cancer"},{"key":"4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2012.02.002","article-title":"Ovarian cancer stem cell markers: prognostic and therapeutic implications","volume":"322","author":"Buckanovich","year":"2012","journal-title":"Cancer Lett"},{"key":"5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/onc.2008.374","article-title":"Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells","volume":"28","author":"Murphy","year":"2009","journal-title":"Oncogene"},{"key":"6","doi-asserted-by":"publisher","first-page":"R59","DOI":"10.1186\/bcr1610","article-title":"CD44+\/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis","volume":"8","author":"Nakshatri","year":"2006","journal-title":"Breast Cancer Res"},{"key":"7","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.cell.2009.10.014","article-title":"An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation","volume":"139","author":"Struhl","year":"2009","journal-title":"Cell"},{"key":"8","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1172\/jci39397","article-title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts","volume":"120","author":"Wicha","year":"2010","journal-title":"J Clin Invest"},{"key":"9","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/jnci\/djr451","article-title":"Differentiation therapy: targeting human renal cancer stem cells with interleukin 15","volume":"103","author":"Eid","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.1002\/ijc.26312","article-title":"The cancer stem cell niche--there goes the neighborhood?","volume":"129","author":"Farrar","year":"2011","journal-title":"Int J Cancer"},{"key":"11","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1158\/0008-5472.can-10-3220","article-title":"Cancer stem cell niche: the place to be","volume":"71","author":"Medema","year":"2011","journal-title":"Cancer Res"},{"key":"12","doi-asserted-by":"publisher","first-page":"6125","DOI":"10.1158\/1078-0432.ccr-10-2743","article-title":"Regulation of cancer stem cells by cytokine networks: attacking cancer's inflammatory roots","volume":"17","author":"Wicha","year":"2011","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.stem.2007.08.001","article-title":"Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4","volume":"1","author":"Stassi","year":"2007","journal-title":"Cell Stem Cell"},{"key":"14","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.4049\/jimmunol.176.3.1908","article-title":"In vitro and in situ expression of IL-23 by keratinocytes in healthy skin and psoriasis lesions: enhanced expression in psoriatic skin","volume":"176","author":"Teunissen","year":"2006","journal-title":"J Immunol"},{"key":"15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Churakova","year":"2000","journal-title":"Immunity"},{"key":"16","first-page":"1355","article-title":"IL-23 promotes growth and proliferation in human squamous cell carcinoma of the oral cavity","volume":"36","author":"Sakashita","year":"2010","journal-title":"Int J Oncol"},{"key":"17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1093\/carcin\/bgs384","article-title":"Interleukin 23 regulates proliferation of lung cancer cells in a concentration-dependent way in association with the interleukin-23 receptor","volume":"34","author":"Lin","year":"2013","journal-title":"Carcinogenesis"},{"key":"18","doi-asserted-by":"publisher","first-page":"e46264","DOI":"10.1371\/journal.pone.0046264","article-title":"Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expression","volume":"7","author":"Guan","year":"2012","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/carcin\/bgu017","article-title":"IL-23 selectively promotes the metastasis of colorectal carcinoma cells with impaired Socs3 expression via the STAT5 pathway","volume":"35","author":"Lin","year":"2014","journal-title":"Carcinogenesis"},{"key":"20","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/mi.2013.101","article-title":"Interleukin-23 is sufficient to induce rapid de novo gut tumorigenesis, independent of carcinogens, through activation of innate lymphoid cells","volume":"7","author":"Basham","year":"2014","journal-title":"Mucosal Immunol"},{"key":"21","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.lungcan.2012.10.003","article-title":"IL-23 is pro-proliferative, epigenetically regulated and modulated by chemotherapy in non-small cell lung cancer","volume":"79","author":"Gray","year":"2013","journal-title":"Lung Cancer"},{"key":"22","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1016\/j.bbrc.2011.10.112","article-title":"STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH(+)\/CD133(+) stem cell-like human colon cancer cells","volume":"416","author":"Lin","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"23","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/bcr2886","article-title":"NF-kappaB, stem cells and breast cancer: the links get stronger","volume":"13","author":"Chariot","year":"2011","journal-title":"Breast Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1002\/stem.1194","article-title":"Autocrine CCL5 signaling promotes invasion and migration of CD133+ ovarian cancer stem-like cells via NF-kappaB-mediated MMP-9 upregulation","volume":"30","author":"Zhu","year":"2012","journal-title":"Stem Cells"},{"key":"25","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/onc.2013.537","article-title":"Interleukin-17 produced by tumor microenvironment promotes self-renewal of CD133+ cancer stem-like cells in ovarian cancer","volume":"34","author":"Zhu","year":"2015","journal-title":"Oncogene"},{"key":"26","doi-asserted-by":"publisher","first-page":"e35069","DOI":"10.1371\/journal.pone.0035069","article-title":"Apilimod inhibits the production of IL-12 and IL-23 and reduces dendritic cell infiltration in psoriasis","volume":"7","author":"Krueger","year":"2012","journal-title":"PLoS One"},{"key":"27","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.1182\/blood-2006-04-019398","article-title":"Selective abrogation of Th1 response by STA-5326, a potent IL-12\/IL-23 inhibitor","volume":"109","author":"Ono","year":"2007","journal-title":"Blood"},{"key":"28","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1002\/cncr.21432","article-title":"Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma","volume":"104","author":"Clark","year":"2005","journal-title":"Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/carcin\/bgh321","article-title":"Oct4 expression in adult human stem cells: evidence in support of the stem cell theory of carcinogenesis","volume":"26","author":"Trosko","year":"2005","journal-title":"Carcinogenesis"},{"key":"30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.bbrc.2009.02.156","article-title":"Embryonic stem cell markers expression in cancers","volume":"383","author":"Klein","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"31","doi-asserted-by":"publisher","first-page":"32800","DOI":"10.1074\/jbc.M111.308528","article-title":"Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma","volume":"287","author":"Chen","year":"2012","journal-title":"J Biol Chem"},{"key":"32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3892\/ijo.2013.1916","article-title":"Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma","volume":"43","author":"Matsuno","year":"2013","journal-title":"Int J Oncol"},{"key":"33","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1093\/carcin\/bgt364","article-title":"Twist2 promotes self-renewal of liver cancer stem-like cells by regulating CD24","volume":"35","author":"Luo","year":"2014","journal-title":"Carcinogenesis"},{"key":"34","doi-asserted-by":"publisher","first-page":"e56399","DOI":"10.1371\/journal.pone.0056399","article-title":"The role of NF-kappaB signaling in the maintenance of pluripotency of human induced pluripotent stem cells","volume":"8","author":"Hishikawa","year":"2013","journal-title":"PLoS One"},{"key":"35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.4162\/nrp.2016.10.2.139","article-title":"Loquat (Eriobotrya japonica) leaf extract inhibits the growth of MDA-MB-231 tumors in nude mouse xenografts and invasion of MDA-MB-231 cells","volume":"10","author":"Kim","year":"2016","journal-title":"Nutr Res Pract"},{"key":"36","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/his.12257","article-title":"Increased SOX2 expression in less differentiated breast carcinomas and their lymph node metastases","volume":"64","author":"Tse","year":"2014","journal-title":"Histopathology"},{"key":"37","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/cdd.2008.20","article-title":"Cancer stem cells--old concepts, new insights","volume":"15","author":"Medema","year":"2008","journal-title":"Cell Death Differ"},{"key":"38","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1007\/s12015-011-9344-5","article-title":"Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches","volume":"8","author":"Simon","year":"2012","journal-title":"Stem Cell Rev"},{"key":"39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.4161\/cc.8.1.7533","article-title":"Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance","volume":"8","author":"Mor","year":"2009","journal-title":"Cell Cycle"},{"key":"40","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1525-1438.2007.01056.x","article-title":"Expression of CD133-1 and CD133-2 in ovarian cancer","volume":"18","author":"Scambia","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"41","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/onc.2010.35","article-title":"CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells","volume":"29","author":"Cho","year":"2010","journal-title":"Oncogene"},{"key":"42","doi-asserted-by":"publisher","first-page":"3186","DOI":"10.1158\/1535-7163.mct-10-0563","article-title":"Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancer","volume":"9","author":"Lopez-Berestein","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"43","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1146\/annurev.immunol.21.120601.141135","article-title":"Does the immune system see tumors as foreign or self?","volume":"21","author":"Pardoll","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"44","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Schreiber","year":"2002","journal-title":"Nat Immunol"},{"key":"45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nrc1586","article-title":"Immunosuppressive networks in the tumour environment and their therapeutic relevance","volume":"5","author":"Zou","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"46","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","article-title":"IL-12 family cytokines: immunological playmakers","volume":"13","author":"Kuchroo","year":"2012","journal-title":"Nat Immunol"},{"key":"47","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.it.2012.07.006","article-title":"Cytokine-induced cytokine production by conventional and innate lymphoid cells","volume":"33","author":"Paul","year":"2012","journal-title":"Trends Immunol"},{"key":"48","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nature11465","article-title":"Adenoma-linked barrier defects and microbial products drive IL-23\/IL-17-mediated tumour growth","volume":"491","author":"Fearon","year":"2012","journal-title":"Nature"},{"key":"49","doi-asserted-by":"publisher","first-page":"4006","DOI":"10.1200\/jco.2009.27.5388","article-title":"Targeting breast cancer stem cells","volume":"28","author":"Wicha","year":"2010","journal-title":"J Clin Oncol"},{"key":"50","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/stem.188","article-title":"Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth","volume":"27","author":"McLendon","year":"2009","journal-title":"Stem Cells"},{"key":"51","doi-asserted-by":"publisher","first-page":"7226","DOI":"10.1158\/0008-5472.can-10-4660","article-title":"STAT3 is necessary for proliferation and survival in colon cancer-initiating cells","volume":"71","author":"Lin","year":"2011","journal-title":"Cancer Res"},{"key":"52","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/stem.110","article-title":"Novel STAT3 target genes exert distinct roles in the inhibition of mesoderm and endoderm differentiation in cooperation with Nanog","volume":"27","author":"Savatier","year":"2009","journal-title":"Stem Cells"},{"key":"53","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.cr.7310125","article-title":"Nanog and transcriptional networks in embryonic stem cell pluripotency","volume":"17","author":"Thomson","year":"2007","journal-title":"Cell Res"},{"key":"54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.stem.2011.06.005","article-title":"CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation","volume":"9","author":"Ng","year":"2011","journal-title":"Cell Stem Cell"},{"key":"55","doi-asserted-by":"publisher","first-page":"e60145","DOI":"10.1371\/journal.pone.0060145","article-title":"Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival","volume":"8","author":"Gallo","year":"2013","journal-title":"PLoS One"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T15:03:26Z","timestamp":1589295806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.12579"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,12]]},"references-count":55,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["12579","27738346"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.12579","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,12]]}}}